ANAB logo

AnaptysBio (ANAB) EBITDA

Annual EBITDA

-$92.74 M
+$50.42 M+35.22%

December 31, 2024

Summary

Performance

1-Year Change

+35.22%

3-Year Change

-70.94%

5-Year Change

+2.42%

15-Year Change

-229.91%

ANAB EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

19.95%
ANAB annual EBITDA is higher than 19.95% of companies in Healthcare sector

High & Low

All-time High

$5.12 M
ANAB annual EBITDA is currently -1911.05% below its historical high of $5.12 million

3-Year Low

-$143.16 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
ANAB previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
ANAB next annual earnings announcement has not yet been scheduled

OtherANABprofitabilitymetrics:

Annual Revenue

$91.28 M
ANAB annual revenue is $91.28 million

Annual Net Income

-$145.23 M
ANAB annual net profit is -$145.23 million

Annual EBIT

-$95.14 M
ANAB annual earnings before interest & taxes is -$95.14 million

Annual EPS

-$5.12
ANAB annual earnings per share is -$5.12

Quarterly EBITDA

-$3.79 M
+$13.06 M+77.53%

December 31, 2024

Summary

Performance

3-Month Change

+77.53%

1-Year Change

+77.53%

3-Year Change

+87.67%

5-Year Change

+80.13%

ANAB Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

52.86%
ANAB quarterly EBITDA is higher than 52.86% of companies in Healthcare sector

High & Low

All-time High

$37.92 M
ANAB quarterly EBITDA is currently -109.98% below its historical high of $37.92 million

3-Year Low

-$39.33 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
ANAB previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 9, 2025
ANAB next earnings announcement is scheduled for May 9, 2025

OtherANABprofitabilitymetrics:

Quarterly Revenue

$43.11 M
ANAB quarterly revenue is $43.11 million

Quarterly Net Income

-$21.78 M
ANAB quarterly net profit is -$21.78 million

Quarterly EBIT

-$4.39 M
ANAB quarterly earnings before interest & taxes is -$4.39 million

Quarterly EPS

-$0.72
ANAB quarterly earnings per share is -$0.72

TTM EBITDA

-$92.74 M
+$32.87 M+26.17%

December 31, 2024

Summary

Performance

3-Month Change

+26.17%

1-Year Change

+26.17%

3-Year Change

-70.94%

5-Year Change

+2.42%

ANAB TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

19.56%
ANAB TTM EBITDA is higher than 19.56% of companies in Healthcare sector

High & Low

All-time High

$14.36 M
ANAB TTM EBITDA is currently -745.71% below its historical high of $14.36 million

3-Year Low

-$143.16 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
ANAB previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 9, 2025
ANAB next earnings announcement is scheduled for May 9, 2025

OtherANABprofitabilitymetrics:

TTM Revenue

$91.28 M
ANAB TTM revenue is $91.28 million

TTM Net Income

-$145.23 M
ANAB TTM net profit is -$145.23 million

TTM EBIT

-$95.14 M
ANAB TTM earnings before interest & taxes is -$95.14 million

TTM EPS

-$5.21
ANAB TTM earnings per share is -$5.21

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$92.74 M
ANAB annual EBITDA is -$92.74 million

Annual Net Income

-$145.23 M
ANAB annual net profit is -$145.23 million

Annual Interest Expense

$50.09 M
ANAB annual interest expense is $50.09 million

Annual Income Tax

$3000.00
ANAB annual income tax is $3000.00

Annual D&A

$2.40 M
ANAB annual depreciation & amortization is $2.40 million

ANAB EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+35.2%+77.5%+26.2%
3 y3 years-70.9%+87.7%-70.9%
5 y5 years+2.4%+80.1%+2.4%

ANAB EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-70.9%+35.2%at high+90.4%-70.9%+35.2%
5 y5-year-406.4%+35.2%-110.0%+90.4%-745.7%+35.2%
alltimeall time-1911.0%+35.2%-110.0%+90.4%-745.7%+35.2%

AnaptysBio EBITDA History

DateAnnualQuarterlyTTM
Dec 2024
-$92.74 M(-35.2%)
-$3.79 M(-77.5%)
-$92.74 M(-26.2%)
Sep 2024
-
-$16.84 M(-52.0%)
-$125.61 M(-10.9%)
Jun 2024
-
-$35.10 M(-5.2%)
-$141.06 M(+0.1%)
Mar 2024
-
-$37.01 M(+1.0%)
-$140.85 M(-1.6%)
Dec 2023
-$143.16 M(+36.0%)
-$36.65 M(+13.5%)
-$143.16 M(+11.8%)
Sep 2023
-
-$32.28 M(-7.5%)
-$128.04 M(+4.5%)
Jun 2023
-
-$34.90 M(-11.3%)
-$122.54 M(+7.7%)
Mar 2023
-
-$39.33 M(+82.6%)
-$113.75 M(+8.1%)
Dec 2022
-$105.26 M(+94.0%)
-$21.53 M(-19.6%)
-$105.26 M(-8.0%)
Sep 2022
-
-$26.78 M(+2.6%)
-$114.43 M(+22.2%)
Jun 2022
-
-$26.11 M(-15.3%)
-$93.64 M(+39.4%)
Mar 2022
-
-$30.83 M(+0.4%)
-$67.17 M(+23.8%)
Dec 2021
-$54.26 M(+196.3%)
-$30.70 M(+412.0%)
-$54.26 M(-477.7%)
Sep 2021
-
-$6.00 M(-1784.6%)
$14.36 M(-494.5%)
Jun 2021
-
$356.00 K(-102.0%)
-$3.64 M(-86.1%)
Mar 2021
-
-$17.91 M(-147.2%)
-$26.11 M(+42.6%)
Dec 2020
-$18.31 M(-80.7%)
$37.92 M(-258.0%)
-$18.31 M(-75.7%)
Sep 2020
-
-$24.00 M(+8.5%)
-$75.28 M(-8.2%)
Jun 2020
-
-$22.12 M(+118.7%)
-$81.99 M(-1.8%)
Mar 2020
-
-$10.11 M(-46.9%)
-$83.49 M(-12.2%)
Dec 2019
-$95.04 M
-$19.05 M(-38.0%)
-$95.04 M(+2.5%)
DateAnnualQuarterlyTTM
Sep 2019
-
-$30.71 M(+30.0%)
-$92.70 M(+19.7%)
Jun 2019
-
-$23.62 M(+9.0%)
-$77.46 M(+15.7%)
Mar 2019
-
-$21.66 M(+29.6%)
-$66.96 M(+11.8%)
Dec 2018
-$59.88 M(+113.0%)
-$16.71 M(+8.1%)
-$59.88 M(+20.9%)
Sep 2018
-
-$15.47 M(+17.9%)
-$49.52 M(+16.1%)
Jun 2018
-
-$13.12 M(-10.0%)
-$42.65 M(+34.4%)
Mar 2018
-
-$14.58 M(+129.3%)
-$31.73 M(+12.9%)
Dec 2017
-$28.11 M(+687.9%)
-$6.36 M(-26.0%)
-$28.11 M(+7.4%)
Sep 2017
-
-$8.59 M(+291.6%)
-$26.16 M(+41.3%)
Jun 2017
-
-$2.19 M(-80.0%)
-$18.51 M(+34.0%)
Mar 2017
-
-$10.97 M(+148.8%)
-$13.82 M(+287.3%)
Dec 2016
-$3.57 M(-21.3%)
-$4.41 M(+368.5%)
-$3.57 M(+48.2%)
Sep 2016
-
-$941.00 K(-137.7%)
-$2.41 M(-10.7%)
Jun 2016
-
$2.50 M(-448.9%)
-$2.69 M(-46.8%)
Mar 2016
-
-$716.00 K(-78.0%)
-$5.06 M(+11.7%)
Dec 2015
-$4.53 M(-188.5%)
-$3.25 M(+164.5%)
-$4.53 M(+550.2%)
Sep 2015
-
-$1.23 M(-1030.3%)
-$697.00 K(-117.1%)
Jun 2015
-
$132.00 K(-170.2%)
$4.07 M(+3.4%)
Mar 2015
-
-$188.00 K(-132.0%)
$3.94 M(-4.6%)
Dec 2014
$5.12 M(-225.5%)
$587.00 K(-83.4%)
$4.12 M(+16.6%)
Sep 2014
-
$3.54 M
$3.54 M
Dec 2013
-$4.08 M
-
-

FAQ

  • What is AnaptysBio annual EBITDA?
  • What is the all time high annual EBITDA for AnaptysBio?
  • What is AnaptysBio annual EBITDA year-on-year change?
  • What is AnaptysBio quarterly EBITDA?
  • What is the all time high quarterly EBITDA for AnaptysBio?
  • What is AnaptysBio quarterly EBITDA year-on-year change?
  • What is AnaptysBio TTM EBITDA?
  • What is the all time high TTM EBITDA for AnaptysBio?
  • What is AnaptysBio TTM EBITDA year-on-year change?

What is AnaptysBio annual EBITDA?

The current annual EBITDA of ANAB is -$92.74 M

What is the all time high annual EBITDA for AnaptysBio?

AnaptysBio all-time high annual EBITDA is $5.12 M

What is AnaptysBio annual EBITDA year-on-year change?

Over the past year, ANAB annual EBITDA has changed by +$50.42 M (+35.22%)

What is AnaptysBio quarterly EBITDA?

The current quarterly EBITDA of ANAB is -$3.79 M

What is the all time high quarterly EBITDA for AnaptysBio?

AnaptysBio all-time high quarterly EBITDA is $37.92 M

What is AnaptysBio quarterly EBITDA year-on-year change?

Over the past year, ANAB quarterly EBITDA has changed by +$13.06 M (+77.53%)

What is AnaptysBio TTM EBITDA?

The current TTM EBITDA of ANAB is -$92.74 M

What is the all time high TTM EBITDA for AnaptysBio?

AnaptysBio all-time high TTM EBITDA is $14.36 M

What is AnaptysBio TTM EBITDA year-on-year change?

Over the past year, ANAB TTM EBITDA has changed by +$32.87 M (+26.17%)